[Is there still no alternative to long-term antibacterial prophylaxis?]

Area of Science:

• Pediatrics
• Infectious Diseases
• Pharmacology

Background:

• Long-term antibacterial prophylaxis is a primary strategy for preventing urinary tract infections (UTIs) in infants and children.
• Concerns regarding antibiotic resistance, chemotherapeutic side effects, and patient acceptance necessitate the exploration of alternative UTI prophylaxis methods.
• D-mannose, probiotics, and herbal preparations are emerging as potential alternatives, but require further clinical validation, particularly in pediatric populations.

Purpose of the Study:

• To review current strategies for UTI prophylaxis in children.
• To discuss the limitations of traditional antibiotic prophylaxis.
• To highlight emerging alternative approaches and the need for evidence-based validation.

Main Methods:

• Literature review of studies on UTI prophylaxis in pediatric populations.
• Analysis of current clinical practices and emerging alternative therapies.
• Evaluation of the evidence supporting non-antibiotic interventions.

Main Results:

• Antibiotic prophylaxis remains a widely used but not universally optimal strategy for pediatric UTIs.
• Alternative agents like D-mannose, probiotics, and herbal preparations show promise but lack robust clinical evidence in children.
• Vaccine prevention approaches also require further investigation.
• Non-pharmacological interventions, including managing bladder dysfunction, constipation, and predisposing factors, are crucial components of comprehensive UTI management.

Conclusions:

• Alternatives to antibiotic prophylaxis for UTIs in children exist and are gaining attention.
• While promising, the efficacy of these alternatives, especially in high-risk cases with recurrent infections or pyelonephritis, requires further robust clinical study.
• Comprehensive management, including addressing underlying factors, is essential alongside any prophylactic strategy.